🇺🇸 FDA
Patent

US 10154970

Methods for immunomodulation of cancer and infectious disease therapy

granted A61KA61K2039/545A61K2039/55

Quick answer

US patent 10154970 (Methods for immunomodulation of cancer and infectious disease therapy) held by The Regents of the University of California expires Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
33
CPC classes
A61K, A61K2039/545, A61K2039/55, A61K31/035, A61K31/055